Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

This study evaluated the efficacy and safety of flecainide in addition to conventional drug therapy in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). CPVT is an inherited arrhythmia syndrome caused by gene mutations that destabilize cardiac ryanodine receptor Ca(2+) rele...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the American College of Cardiology Vol. 57; no. 22; p. 2244
Main Authors:	van der Werf, Christian, Kannankeril, Prince J, Sacher, Frederic, Krahn, Andrew D, Viskin, Sami, Leenhardt, Antoine, Shimizu, Wataru, Sumitomo, Naokata, Fish, Frank A, Bhuiyan, Zahurul A, Willems, Albert R, van der Veen, Maurits J, Watanabe, Hiroshi, Laborderie, Julien, Haïssaguerre, Michel, Knollmann, Björn C, Wilde, Arthur A M
Format:	Journal Article
Language:	English
Published:	United States 31.05.2011
Subjects:	Adolescent Adult Aged Anti-Arrhythmia Agents - administration & dosage Anti-Arrhythmia Agents - pharmacology Anti-Arrhythmia Agents - therapeutic use Arrhythmias, Cardiac - prevention & control Child Defibrillators, Implantable Dose-Response Relationship, Drug Exercise Test Female Flecainide - administration & dosage Flecainide - pharmacology Flecainide - therapeutic use Humans Male Middle Aged Polymorphic Catecholaminergic Ventricular Tachycardia Retrospective Studies Tachycardia, Ventricular - drug therapy Young Adult
ISSN:	1558-3597, 1558-3597
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!